# Aspire Fertility Institute Austin – FDA Inspection, Dec 19, 2023

Source: https://www.keypedia.com/records/fda_inspections/aspire-fertility-institute-austin/dbe9a1b8-81a2-44ec-9ac6-e42c16925856
Source feed: FDA_Inspections

> FDA inspection 1225632 of Aspire Fertility Institute Austin, December 19, 2023. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225632
- Company Name: Aspire Fertility Institute Austin
- Inspection Date: 2023-12-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1081257 - 2019-02-07
- [FDA Inspection 921252 - 2015-03-30](https://www.keypedia.com/records/fda_inspections/aspire-fertility-institute-austin/27a6467c-3e07-4087-a3bd-aa9ad6ed624d)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/maira-p-brading/892072f4-e584-48d1-890c-e0a47dfbdffa)

Company: https://www.keypedia.com/companies/aspire-fertility-institute-austin/ac268b1b-b02c-4e02-9a8e-ad95493fb424

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d